Overview

A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to test the effect of MK-0941 as add-on therapy for participants taking metformin for type 2 diabetes.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Glimepiride
Metformin
Criteria
Inclusion Criteria:

- Patient has type 2 diabetes mellitus

- Between the ages of 18 and 70

Exclusion Criteria:

- Patient has a history of type 1 diabetes mellitus or ketoacidosis.

- Patient is on a weight loss program and is not in the maintenance phase or is taking
weight loss medication.

- Patient has had surgery within 30 days of starting the study or has planned major
surgery during the study